CD274 and cancer: Although a part of the response may originate from allogenicity rather than specific recognition of cancer cells, strong anti-cancer activity was also seen in all three PDX models treated with autologous (and hence HLA matched) AII cells and anti-PDL1, demonstrating that allogenicity is not a requirement for cancer cell detection and destruction by AII.